Lantheus Holdings Inc (NASDAQ: LNTH) is a radiopharmaceutical company that develops, manufactures, and commercializes diagnostic and therapeutic agents used in medical imaging and targeted oncology. The filing excerpts provided do not contain sufficient detail to characterize revenue streams, segment mix, customer concentration, competitive position, or leadership with the specificity required for a source-grounded description. Based solely on the available filing content, no further claims about revenue model, market position, geographic footprint, or business quality can be supported.

Source: SEC 10-K, filed 2026-02-26

Industry: In Vitro & In Vivo Diagnostic Substances Peers: Align Technology Inc Cooper Companies Inc QuidelOrtho Corp DENTSPLY SIRONA Inc Haemonetics Corp ICU Medical Inc Neogen Corp STAAR Surgical Co